85 related articles for article (PubMed ID: 31512619)
21. An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins.
Hirota T; Fujita Y; Ieiri I
Expert Opin Drug Metab Toxicol; 2020 Sep; 16(9):809-822. PubMed ID: 32729746
[TBL] [Abstract][Full Text] [Related]
22. Lipid-Modifying Therapies and Stroke Prevention.
Hackam DG; Hegele RA
Curr Neurol Neurosci Rep; 2022 Jul; 22(7):375-382. PubMed ID: 35554824
[TBL] [Abstract][Full Text] [Related]
23. Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults.
Zhou Z; Ryan J; Ernst ME; Zoungas S; Tonkin AM; Woods RL; McNeil JJ; Reid CM; Curtis AJ; Wolfe R; Wrigglesworth J; Shah RC; Storey E; Murray A; Orchard SG; Nelson MR;
J Am Coll Cardiol; 2021 Jun; 77(25):3145-3156. PubMed ID: 34167639
[TBL] [Abstract][Full Text] [Related]
24. Clinical conundrums involving statin drug-drug interactions.
Lamprecht DG; Saseen JJ; Shaw PB
Prog Cardiovasc Dis; 2022; 75():83-89. PubMed ID: 36400235
[TBL] [Abstract][Full Text] [Related]
25. Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer.
Morofuji Y; Nakagawa S; Ujifuku K; Fujimoto T; Otsuka K; Niwa M; Tsutsumi K
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215263
[TBL] [Abstract][Full Text] [Related]
26. Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.
Lee M; Cheng CY; Wu YL; Lee JD; Hsu CY; Ovbiagele B
JAMA Neurol; 2022 Apr; 79(4):349-358. PubMed ID: 35188949
[TBL] [Abstract][Full Text] [Related]
27. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.
Cai T; Abel L; Langford O; Monaghan G; Aronson JK; Stevens RJ; Lay-Flurrie S; Koshiaris C; McManus RJ; Hobbs FDR; Sheppard JP
BMJ; 2021 Jul; 374():n1537. PubMed ID: 34261627
[TBL] [Abstract][Full Text] [Related]
28. Management of Acute Ischemic Stroke.
Herpich F; Rincon F
Crit Care Med; 2020 Nov; 48(11):1654-1663. PubMed ID: 32947473
[TBL] [Abstract][Full Text] [Related]
29. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
30. Cerebrovascular Disease and Statins.
Beltrán Romero LM; Vallejo-Vaz AJ; Muñiz Grijalvo O
Front Cardiovasc Med; 2021; 8():778740. PubMed ID: 34926626
[TBL] [Abstract][Full Text] [Related]
31. Statin use and the risk of post-stroke seizures: A meta-analysis.
Xu T; Wang Y; Yuan J; Chen Y; Luo H
Seizure; 2020 Dec; 83():63-69. PubMed ID: 33096458
[TBL] [Abstract][Full Text] [Related]
32. The influence of statin withdrawal and adherence on stroke outcomes.
Vitturi BK; Gagliardi RJ
Neurol Sci; 2021 Jun; 42(6):2317-2323. PubMed ID: 33037514
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic management of ischemic stroke.
Bindal P; Kumar V; Kapil L; Singh C; Singh A
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2651-2679. PubMed ID: 37966570
[TBL] [Abstract][Full Text] [Related]
34. New Strategies for Stroke Therapy: Nanoencapsulated Neuroglobin.
Blanco S; Martínez-Lara E; Siles E; Peinado MÁ
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015363
[TBL] [Abstract][Full Text] [Related]
35. Deregulation of Cholesterol Homeostasis by a Nuclear Hormone Receptor Crosstalk in Advanced Prostate Cancer.
Yang N; Yang Y; Huang Z; Chen HW
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804882
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Genetic Associations Between the Use of Statins and Alzheimer's Disease.
Lee J; Park S; Kim Y; Kim HM; Oh CM
J Lipid Atheroscler; 2022 May; 11(2):133-146. PubMed ID: 35656152
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy.
Saavedra K; Leal K; Saavedra N; Prado Y; Paez I; Ubilla CG; Rojas G; Salazar LA
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563413
[TBL] [Abstract][Full Text] [Related]
38. Microglial phagocytosis and regulatory mechanisms after stroke.
Chen W; Zhang Y; Zhai X; Xie L; Guo Y; Chen C; Li Y; Wang F; Zhu Z; Zheng L; Wan J; Li P
J Cereb Blood Flow Metab; 2022 Sep; 42(9):1579-1596. PubMed ID: 35491825
[TBL] [Abstract][Full Text] [Related]
39. From Blood to Regenerative Tissue: How Autologous Platelet-Rich Fibrin Can Be Combined with Other Materials to Ensure Controlled Drug and Growth Factor Release.
Egle K; Salma I; Dubnika A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768984
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
